Michael Crager

1.5k total citations
39 papers, 1.0k citations indexed

About

Michael Crager is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael Crager has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Oncology. Recurrent topics in Michael Crager's work include Breast Cancer Treatment Studies (12 papers), Statistical Methods in Clinical Trials (9 papers) and Prostate Cancer Treatment and Research (7 papers). Michael Crager is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Statistical Methods in Clinical Trials (9 papers) and Prostate Cancer Treatment and Research (7 papers). Michael Crager collaborates with scholars based in United States, United Kingdom and Canada. Michael Crager's co-authors include Bernard Chaitman, Adam Timmis, Steven Shak, Gong Tang, Michael Sweeney, Michael J. Koren, Stephen A. Spector, Norman Wolmark, Robert J. Gray and Joseph A. Sparano and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Michael Crager

39 papers receiving 978 citations

Peers

Countries citing papers authored by Michael Crager

Since Specialization

Citations

This map shows the geographic impact of Michael Crager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Crager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Crager more than expected).

Fields of papers citing papers by Michael Crager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Crager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Crager. The network helps show where Michael Crager may publish in the future.

Co-authorship network of co-authors of Michael Crager

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Crager. A scholar is included among the top collaborators of Michael Crager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Crager. Michael Crager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin 2022 ·Journal of Gastrointestinal Oncology ·Greg Yothers, Alan P. Venook, Eiji Oki, Donna Niedzwiecki, Yan Lin, Michael Crager, Calvin Chao, Frederick L. Baehner, Norman Wolmark, Takayuki Yoshino	2
2	Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer 2022 ·Breast Cancer Research ·Michael Crager, Sameera R. Wijayawardana, Aaron M. Gruver, (unknown), Christy Russell, Frederick L. Baehner, Francisco Sapunar	7
3	Validating the association of adverse pathology with distant metastasis and prostate cancer mortality 20-years after radical prostatectomy 2021 ·Urologic Oncology Seminars and Original Investigations ·(unknown), Lewis J. Thomas, Cristina Magi‐Galluzzi, Jianbo Li, Michael Crager, Ruixiao Lu, Frederick L. Baehner, (unknown), Tamer Aboushwareb, Eric A. Klein	6
4	GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality 2021 ·JCO Precision Oncology ·(unknown), Lewis J. Thomas, Cristina Magi‐Galluzzi, Jianbo Li, Michael Crager, Ruixiao Lu, (unknown), Tamer Aboushwareb, Eric A. Klein	19
5	Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance 2020 ·Lifetime Data Analysis ·Michael Crager	2
6	Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies 2018 ·Breast Cancer Research and Treatment ·Eileen Rakovitch, Robert J. Gray, Frederick L. Baehner, Rinku Sutradhar, Michael Crager, (unknown), Sharon Nofech‐Mozes, Sunil Badve, Wedad Hanna, Lorie L. Hughes, W. C. Wood, Nancy E. Davidson, Lawrence Paszat, Steven Shak, Joseph A. Sparano, Lawrence J. Solin	44
7	21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer 2018 ·npj Breast Cancer ·Charles E. Geyer, (unknown), Eleftherios P. Mamounas, Priya Rastogi, Soonmyung Paik, Steven Shak, Frederick L. Baehner, Michael Crager, D. Lawrence Wickerham, Joseph P. Costantino, Norman Wolmark	63
8	Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer 2017 ·Contemporary Clinical Trials ·Holly Janes, Marshall Brown, Michael Crager, Dave P. Miller, William E. Barlow	2
9	A 17-gene genomic prostate score (GPS) as a predictor of biochemical (BCR) and clinical recurrence (CR) in men with surgically treated intermediate- and high-risk prostate cancer (PCa). 2016 ·Journal of Clinical Oncology ·Eric A. Klein, Timothy C. Brand, Inger L. Rosner, Nan Zhang, Michael Crager, Tara Maddala, Phillip G. Febbo, Shibu Thomas, Michael Gormley, Deborah Ricci, Sara M. Falzarano, Cristina Magi‐Galluzzi, Jennifer Cullen, Isabell A. Sesterhenn, H. Jeffrey Lawrence	1
10	Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate Score 2015 ·Urology ·Timothy C. Brand, Nan Zhang, Michael Crager, Tara Maddala, Anne Dee, Isabell A. Sesterhenn, Jeffry Simko, Matthew R. Cooperberg, Shiv Srivastava, Inger L. Rosner, June M. Chan, Phillip G. Febbo, Peter R. Carroll, Jennifer Cullen, H. Jeffrey Lawrence	37
11	Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression 2014 ·Journal of Applied Statistics ·Michael Crager, Gong Tang	5
12	Whole Transcriptome RNA-Seq Analysis of Breast Cancer Recurrence Risk Using Formalin-Fixed Paraffin-Embedded Tumor Tissue 2012 ·PLoS ONE ·Dominick Sinicropi, Kunbin Qu, François Collin, Michael Crager, Mei‐Lan Liu, Robert J. Pelham, Mylan Pho, Andrew Dei Rossi, Jennie Jeong, Aaron Scott, (unknown), Christina Zheng, Raul Mena, José Miguel Esteban López-Jamar, James C. Stephans, John Morlan, Joffre Baker	59
13	Identification of prostate cancer-expressed microRNAs associated with clinical recurrence (cR) and prostate cancer-specific survival (PCSS) following radical prostatectomy (RP). 2012 ·Journal of Clinical Oncology ·Eric A. Klein, (unknown), Michael Crager, Cristina Magi‐Galluzzi, Sara M. Falzarano, Robert J. Pelham, Carl Millward, Diana B. Cherbavaz, Joffre Baker, Steven Shak, Mark Lee	1
14	Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean 2009 ·Statistics in Medicine ·Michael Crager	8
15	Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina 2007 ·Journal of the American College of Cardiology ·Michael J. Koren, Michael Crager, Michael Sweeney	81
16	Safety and Efficacy of Extended‐Release Ranolazine in Patients Aged 70 Years or Older With Chronic Stable Angina Pectoris 2007 ·The American Journal of Geriatric Cardiology ·Michael W. Rich, Michael Crager, Charles R. McKay	23
17	Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetes 2005 ·European Heart Journal ·Adam Timmis, Bernard Chaitman, Michael Crager	131
18	Cytomegalovirus (CMV) DNA Load Is an Independent Predictor of CMV Disease and Survival in Advanced AIDS 1999 ·Journal of Virology ·Stephen A. Spector, (unknown), Michael Crager, (unknown), (unknown), Mary Jean Stempien	97
19	A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDS 1993 ·The Journal of Infectious Diseases ·Stephen A. Spector, T. A. Weingeist, Richard B. Pollard, Douglas T. Dieterich, (unknown), Constance A. Benson, David F. Busch, William R. Freeman, Paul Montague, (unknown), Lisa Kellerman, Michael Crager, (unknown), William Buhles, Judith Feinberg, (unknown)	93
20	Running Average Analysis of Clinical Trial Ambulatory Blood Pressure Data 1991 ·Biometrics ·Michael Crager, Martha Reitman	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact